Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
Kazakhstan's pharmaceutical and medicine production declines by 18%.
Pharmaceutical companies produced only 162.6 billion tenge last year, compared to 198.7 billion tenge in 2021.
In value terms, Kazakhstan's production of medicines and pharmaceuticals has decreased by 18.2% in the last year. Pharmaceutical companies produced only 162.6 billion tenge last year, compared to 198.7 billion tenge in 2021, according to El.kz, citing Energyprom.kz.
During this time, drug production fell by 4.5% while other product production in the pharmaceutical industry fell by 61.1%.
"The most notable event in the industry was the suspension of large-scale production of pharmaceutical products to combat coronavirus infection. First and foremost, this is true of the Sputnik V vaccine. The Karaganda pharmaceutical complex created it. After the vaccine was released in 2022, the figures dropped 2.5 times, to 19.1 billion tenge “according to the report.
"Furthermore, domestic statisticians reported an increase in the volume of imported pharmaceutical revenues last year. Kazakhstan purchased over 26.4 thousand tonnes of pharmaceuticals and medicines worth approximately $ 1.4 billion between January and December 2022. Growth was observed in both physical volume (plus 21.8%) and value (plus 25%) "cited the report.